Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Trials still pending Two core obesity trials are still running: TRIUMPH-2 (obesity + type 2 diabetes) results expected later 2026 TRIUMPH-3 (obesity + established cardiovascular disease) results expected later 2026 A separate cardiovascular outcomes trial, TRIUMPH-Outcomes (~10,000 patients), is not required for the initial obesity NDA and wont report until 20282029
Specifically, copper's ability to enhance MMP expression, particularly MMP-1, which regulates collagen breakdown, might lead to a temporary increase in cellular debris or a transient inflammatory response as the skin purges and rebuilds
Espada, L
Enhanced Quality of Life In patients with advanced cancer, hydrogen inhalation has been associated with improved quality of life and, in some cases, slowed disease progression